Overexpression or aberrant activation of EGFR has been demonstrated to cause tumor growth and progression of NSCLC (Dacic et al., 2006; Fontanini et al., 1995; Normanno et al., 2005). Here, EGFR is linked to non-small cell lung carcinoma.